PubRank

S Romain

Author PubWeight™ 26.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]. Bull Cancer 1991 1.63
2 Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 2001 1.55
3 Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer 1995 1.51
4 Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer 2010 1.37
5 Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 1997 1.29
6 Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995 1.27
7 Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival. Br J Cancer 2006 1.21
8 Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 1992 1.05
9 S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Clin Cancer Res 2001 1.01
10 Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol 1995 0.95
11 c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur J Cancer 1992 0.93
12 Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Cancer Res 2001 0.92
13 Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer. Int J Biol Markers 2006 0.91
14 Prognostic value of epidermal growth factor receptor in node-positive breast cancer. Breast Cancer Res Treat 1989 0.90
15 Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients. J Clin Oncol 2001 0.88
16 Inflammatory carcinoma of the breast. Eur J Gynaecol Oncol 1992 0.87
17 DNA and cell cycle analysis as prognostic indicators in breast tumors revisited. Clin Lab Med 2001 0.86
18 Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry 2001 0.84
19 Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer. Int J Biol Markers 2003 0.83
20 Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. Int J Cancer 1998 0.81
21 Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study. Br J Cancer 1999 0.81
22 Correlation of erbB-2 gene amplification with low levels of estrogen and/or progesterone receptors in primary breast cancer: do erbB-2 products delineate hormone-independent tumors? Biomed Pharmacother 1989 0.80
23 Acidification reveals a greater number of epidermal growth factor receptors in human placental and breast cancer membranes. Clin Chim Acta 1994 0.78
24 [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction]. Bull Cancer 1999 0.78
25 [Publication of biological samples collections catalogues by tumor banks]. Bull Cancer 2010 0.78
26 A nomogram to predict individual prognosis in node-negative breast carcinoma. Eur J Cancer 2012 0.77
27 Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study. Breast Cancer Res Treat 1994 0.76
28 Prognostic significance of autoantibodies to laminin in the sera of breast cancer patients: a preliminary report. Eur J Clin Chem Clin Biochem 1994 0.76
29 [Contribution of biology to the therapeutic decision: cancer of the breast in 1995]. Bull Cancer Radiother 1995 0.75
30 EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols. Anticancer Res 2000 0.75
31 [Results of the conservative surgical and irradiation treatment of 132 nonpalpable ductal carcinomas in situ of the breast]. Cancer Radiother 1998 0.75
32 Estrogen and progesterone receptors in breast cancer microsamples simultaneously quantified by enzyme-ligand immunoassay. Clin Chem 1995 0.75
33 [Tissular prognostic factors in cancerology: modalities for evaluation and validation. Groupe de biopathologie tissulaire et moléculaire]. Bull Cancer 1995 0.75
34 Biochemical and immunohistochemical multiparametric analysis of steroid receptors and growth factor receptors in human normal endometrium in spontaneous cycles and after the induction of ovulation. Hum Reprod 1994 0.75
35 Postnatal depression. Facilitating peer group support. Health Visit 1995 0.75
36 Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer. Int J Biol Markers 2017 0.75
37 [Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities]. Bull Cancer 1999 0.75